packageDasatinib

dasatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Dasatinib is a tyrosine-kinase inhibitor used to treat certain leukemias, including chronic myelogenous leukemia and precursor lymphoblastic leukemia-lymphoma. It is an approved medicine, authorised in the European Union, and is included on the WHO list of essential medicines.

Summary written by glm-5.3-flash from Wikidata Q419940 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:dasatinib
ATC codes:L01EA02
DrugBank:DB01254
PubChem CID:3062316
ChEBI:49375
Wikidata:Q419940
formula:C22H26ClN7O2S
molar mass:488.007 g/mol (PubChem CID 3062316)
logP:3.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown